Aspire Biopharma Holdings, Inc. (ASBP)
NASDAQ: ASBP · Real-Time Price · USD
1.140
+0.080 (7.55%)
At close: Apr 13, 2026, 4:00 PM EDT
1.100
-0.040 (-3.51%)
After-hours: Apr 13, 2026, 5:59 PM EDT

Aspire Biopharma Holdings Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Sep '21
Cash & Equivalents
---0.5-
Cash & Short-Term Investments
---0.5-
Inventory
0.25----
Other Current Assets
--0.080.6-
Total Current Assets
1.310.150.081.1-
Long-Term Investments
--19.9299-
Other Long-Term Assets
---0.080.23
Total Assets
1.310.1519.98300.180.23
Accounts Payable
--0.150.180
Accrued Expenses
1.01---0.01
Short-Term Debt
4.181.270.01-0.21
Other Current Liabilities
1.39-0.240.12-
Total Current Liabilities
6.581.270.40.30.23
Other Long-Term Liabilities
0.1--10.81-
Total Long-Term Liabilities
0.1--10.81-
Total Liabilities
6.671.270.411.120.23
Common Stock
00000
Additional Paid-in Capital
20.881.2410.96-0.02
Retained Earnings
---11.29-9.94-0.02
Total Common Shareholders' Equity
20.881.24-0.32-9.940
Minority Interest
--19.9299-
Shareholders' Equity
20.881.2419.58289.070
Total Liabilities & Equity
1.310.1519.98300.180.23
Total Debt
4.181.270.0100.21
Net Cash (Debt)
-4.18-1.27-0.010.5-0.21
Net Cash Per Share
-2.79-1.84-0.3212.95-
Book Value
20.881.24-0.32-9.940
Book Value Per Share
13.971.79-8.39-258.89-
Tangible Book Value
20.881.24-0.32-9.940
Tangible Book Value Per Share
13.971.79-8.39-258.89-
Updated Mar 30, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q